Cite Filings / CATX / 9999999995-25-001029

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Perspective Therapeutics, Inc. Filed 2025-04-08 Acc 9999999995-25-001029

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2025-04-11 8-K Other events
2025-04-08 EFFECT Notice of Effectiveness
2025-04-04 POS AM Post-effective Amendment for Registration Statement
2025-04-01 4 Chief Executive Officer bought 26,676 shares at an average $2.24 ($59,673)
2025-04-01 4 Director bought 60,337 shares at an average $2.19 ($132,151)
2025-04-01 4 Chief Financial Officer bought 33,333 shares at $2.25 ($74,946)
2024-04-09 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…